ABCO - The Advisory Board Company

. Currency in USD
-
-
Stock chart is not supported by your current browser
Previous CloseN/A
OpenN/A
BidN/A x N/A
AskN/A x N/A
Day's RangeN/A - N/A
52 Week Rangeundefined - undefined
VolumeN/A
Avg. VolumeN/A
Market CapN/A
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Capital Cube11 months ago

    The Advisory Board Co. – Value Analysis (NASDAQ:ABCO) : November 17, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives The Advisory Board Co. a score of 47. Our analysis is based on comparing The Advisory Board Co. with the following peers – Gartner, Inc., National Research Corporation Class B, INC Research Holdings, Inc. Class A and Quest Diagnostics Incorporated (IT-US, NRCIB-US, INCR-US and DGX-US). Investment Outlook ... Read more (Read more...)

  • How Health Systems Can Earn Growth with Customer-Centric Strategies
    PR Newswire11 months ago

    How Health Systems Can Earn Growth with Customer-Centric Strategies

    Advisory Board provides insights on consumer understanding, service redesign, and targeted marketing to break through growth stagnation WASHINGTON , Nov. 16, 2017 /PRNewswire/ -- Health systems can no ...

  • The Advisory Board Company Stockholders Approve Merger Agreement With Optum
    PR Newswire11 months ago

    The Advisory Board Company Stockholders Approve Merger Agreement With Optum

    WASHINGTON and BOSTON, Nov. 15, 2017 /PRNewswire/ -- The Advisory Board Company (ABCO) and Optum announced that, at a special meeting of Advisory Board stockholders held today, stockholders holding a majority of the outstanding shares of the company's common stock voted to approve the adoption of the previously disclosed merger agreement with Optum. Pursuant to the agreement, Optum will acquire Advisory Board through a merger and, as previously disclosed, Advisory Board will sell its education business to affiliates of Vista Equity Partners prior to the closing of the merger, which is expected to be completed Friday, November 17, 2017.

  • Hospital Revenue Cycles Showing Strength But Risks Include Denials
    PR Newswire11 months ago

    Hospital Revenue Cycles Showing Strength But Risks Include Denials

    WASHINGTON, Nov. 14, 2017 /PRNewswire/ -- Hospitals and health systems have been improving important portions of their revenue cycle performance over the past two years but face rising risks from increased denial writeoffs, bad debt, and inefficiencies revealed by their persistently high costs to collect, according to Advisory Board's latest Revenue Cycle Survey. Notably, a median 350-bed hospital would have lost $3.5 million to increased denial writeoffs from health care payers over the past four years, the benchmarks show. "Across the revenue cycle as a whole, the benchmarks are encouraging and yet show the risks of complacency," said Jim Lazarus, National Partner, Technology at Advisory Board.

  • Why Hospitals Are Redesigning Their Partnerships with Physicians for the Future
    PR Newswire11 months ago

    Why Hospitals Are Redesigning Their Partnerships with Physicians for the Future

    Advisory Board's national partners share insights on how leading providers are reducing care variation to cut costs and improve patient outcomes WASHINGTON , Nov. 13, 2017 /PRNewswire/ -- As more costs ...

  • Associated Press11 months ago

    Advisory Board misses Street 3Q forecasts

    On a per-share basis, the Washington-based company said it had profit of 2 cents. Earnings, adjusted for one-time gains and costs, came to 27 cents per share. The results did not meet Wall Street expectations. ...

  • PR Newswire11 months ago

    The Advisory Board Company Reports Third Quarter 2017 Results

    WASHINGTON , Nov. 8, 2017 /PRNewswire/ --  The Advisory Board Company (NASDAQ: ABCO) today announced financial results for the third quarter and nine-month period ended September 30, 2017 . Third Quarter ...

  • Advisory Board Company Sees IBD RS Rating Climb To 72
    Investor's Business Daily11 months ago

    Advisory Board Company Sees IBD RS Rating Climb To 72

    A Relative Strength Rating upgrade for Advisory Board Company shows improving technical performance. Will it continue?

  • Stocks With Rising Relative Strength: Advisory Board Company
    Investor's Business Dailylast year

    Stocks With Rising Relative Strength: Advisory Board Company

    Advisory Board Company shows improving price performance, earning an upgrade to its IBD Relative Strength Rating